Rhythm Pharmaceuticals, Inc. Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.15M23.64M77.43M130.13M
Cost of Revenue 0.60M2.13M9.30M13.37M
Gross Profit 2.56M21.50M68.13M116.76M
Operating items
Research & Development 19.59M22.89M50.34M109.45M104.13M108.63M134.95M237.96M
Selling, General & Administrative 6.31M9.52M28.08M36.55M68.49M92.03M117.53M144.30M
Other Operating Expenses 0.60M2.13M9.30M13.37M
Operating Expenses 25.91M32.41M78.42M146.00M173.21M202.79M261.79M395.63M
Operating Income -25.91M-32.41M-78.42M-146.00M-170.06M-179.16M-184.36M-265.50M
EBIT -25.91M-32.41M-78.42M-146.00M-170.06M-179.16M-184.36M-265.50M
Non-operating items
Interest & Investment Income 0.03M0.57M4.35M5.27M0.45M4.03M13.95M14.71M
Other Non Operating Income 100.00M-0.79M0.19M8.90M
Non Operating Income 0.03M-1.30M4.35M5.27M100.45M-1.96M0.24M5.25M
Net income details
EBT -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.11M-260.26M
Tax Provisions 0.56M0.35M
Profit After Tax -25.87M-33.71M-74.06M-140.73M-69.61M-181.12M-184.68M-260.60M
Income from Continuing Operations -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.68M-260.60M
Consolidated Net Income -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.68M-260.60M
Income towards Parent Company -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.68M-260.60M
Net Income towards Common Stockholders -25.87M-31.85M-74.06M-140.73M-69.61M-181.12M-184.68M-264.57M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 27.28M34.41M43.93M44.20M50.27M56.35M59.10M61.46M
Shares Outstanding (Diluted Average) 36.42M49.60M52.12M57.67M61.00M
EBITDA -25.91M-32.41M-78.42M-146.00M-170.06M-179.16M-184.36M-265.50M